Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.3 USD | +0.68% | +15.26% | +68.57% |
01/04 | Solid Biosciences' SGT-003 Receives US FDA's Rare Pediatric Disease Label | MT |
01/04 | Solid Biosciences Gets FDA Rare-Pediatric Designation for SGT-003 in Duchenne | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+68.57% | 387M | |
-1.04% | 103B | |
+8.38% | 101B | |
+4.40% | 23.07B | |
-12.15% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.46% | 16.94B | |
+6.72% | 14.07B | |
+39.36% | 12.35B |
- Stock Market
- Equities
- SLDB Stock
- News Solid Biosciences Inc.
- Piper Sandler Adjusts Price Target on Solid Biosciences to $2 From $5, Maintains Neutral Rating